Breast Cancer

A new test specifically designed for breast cancer patients with DCIS appears to be a better indicator of recurrence than other assays for more invasive forms of the disease.

Patients who undergo chemotherapy for breast cancer may develop fatigue that remains problematic long after they complete treatment.

Adjuvant chemotherapy improves disease-free and overall survival in many--but not all--patients with breast cancer.

Dr. J. Michael Dixon, from the University of Edinburgh, Discusses Making the Decision to have a Mastectomy

As research progresses, optimal treatment of breast cancer will involve individualization of therapy to focus on specific targets driving each patient's cancer.

Dr. Charles Perou, from the UNC Lineberger Comprehensive Cancer Center, on Next Generation Sequencing Technology

Dr. Julie Gralow, from the Seattle Cancer Care Alliance, on Treating Breast Cancer Bone Metastases

For locally advanced breast cancer, molecular profiling may be an effective way to determine which patients respond better to certain therapies.

Dr. Edith Perez, from the Mayo Clinic Cancer Center, Discusses Adjuvant Chemotherapy Patient Selection

Dr. Matthew Ellis, from Siteman Cancer Center, Describes Breast Cancer Heterogeneity

The US Supreme Court has asked an appellate court to reconsider its decision regarding patents held on two genes.

HER2 status in patients with breast cancer has emerged as a durable and effective marker for evaluating tumors and selecting therapies.

Dr. Neil Spector, from the Duke Cancer Institute, Discusses the Complexities of Cancer

Dr. Nancy Davidson, from the University of Pittsburgh Cancer Institute, Discusses Breast Cancer Chemoprevention

Dr. Jenny Chang, from the Methodist Cancer Center, Discusses Combining HER2 Targeted Therapies

Dr. Patrick Borgen, from the Maimonides Breast Cancer Center, Discusses the Negative Effects of Pinkwashing

Contrary to earlier findings, surgical breast biopsies may not be as overused as previously thought, according to a recent study published in the Journal of the American College of Radiology.

Dr. Debu Tripathy, from the USC Norris Comprehensive Cancer Center, Discusses Breast Cancer Prevention

Recognition of breast cancer subtypes and research into their underlying biologies is driving the development of new therapies.

Dr. Julie Gralow, from the Seattle Cancer Care Alliance, on Adjuvant Bisphosphonates for Breast Cancer

Next-generation immunotherapy in breast cancer treatment is an active field of scientific exploration with the potential to yield a vaccine.

Dr. Daniel Osman, the program chair for the Miami Breast Cancer Conference, Discusses the 29th Annual Meeting

Technological advances in genomics have prompted a "sea change" in breast cancer drug development and treatment.

The choice of breast-conserving surgery over mastectomy is often based on fear of recurrence and death rather than clinical evidence.

Debu Tripathy, MD, culled the highlights from abstracts presented in 2011 at the ASCO annual meeting in Chicago, Illinois, and at the CCTR-AARC SABCS in Texas.